The effects of BAY-I treatment on CD8+ T cells appeared to be tumor-specific, as CD8+ T cell numbers were not changed in other organs, such as the spleen, lung and liver, in the same animals (Supplementary Fig. 3A and Fig. 4C). Here, CD8A is linked to neoplasm.